Narayana Hrudayalaya Ltd.
NSE: NH · Hospital
Snapshot
Unlock Narayana Hrudayalaya Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Narayana Hrudayalaya Limited is a healthcare provider operating a network of hospitals, clinics, and heart centres. The company offers a wide range of medical specialties including cardiology, oncology, and neurology across India and the Cayman Islands.
Business Model
The company generates revenue through the provision of medical and surgical healthcare services across its hospital network. Additionally, it earns income from healthcare consultancy services and the licensing of proprietary ERP solutions.
- Owned/Operated Hospitals:19
- Managed Hospitals:2
- Heart Centres:4
- Clinics and Information Centres:18
Growth Outlook
Growth is driven by the expansion of the hospital network and the scaling of specialised medical services. The company continues to leverage its healthcare consultancy and technology licensing to diversify revenue streams.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Talent Retention. The company's performance is highly dependent on its ability to attract and retain skilled medical professionals and surgeons.
- Operational Risk. Maintaining high standards of clinical outcomes and patient safety across a geographically dispersed network presents significant operational challenges.
- Competitive Pressure. The healthcare sector in India is highly fragmented and competitive, which may lead to pricing pressures and increased marketing costs.
Start your research today
Unlock AI insights, financials, peers and live data on Narayana Hrudayalaya Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹10,273 Cr
TTM · consolidated
NET PROFIT
₹859 Cr
TTM · consolidated
EPS
₹42.28
TTM · consolidated
RETURN ON EQUITY
19.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
15.7%
TTM · consolidated
P/E
43.4×
Q2 FY27 · consolidated
EV/EBITDA
20.6x
Q2 FY27 · consolidated
EBITDA MARGIN
19.9%
TTM · consolidated
NET PROFIT MARGIN
10.6%
Q2 FY27 · consolidated
DEBT TO EQUITY
1.0x
Q2 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Narayana Hrudayalaya Ltd.NH | ₹37,484 Cr | 43.4× | 20.56 | 71.4% | 19.9% | 19.0% | 15.7% | +4.4% |
Aster DM Quality Care LimitedASTERDM | ₹58,738 Cr | 109.0× | 54.45 | 15.7% | 22.3% | 9.1% | 10.5% | -0.6% |
Fortis Healthcare Ltd.FORTIS | ₹57,490 Cr | 54.9× | 27.49 | 17.5% | 22.9% | 11.4% | 13.0% | -25.6% |
Global Health Ltd.MEDANTA | ₹34,910 Cr | 62.7× | 33.33 | 21.3% | 23.0% | 15.0% | 17.2% | -1.0% |
Krishna Institute Of Medical Sciences LtdKIMS | ₹30,278 Cr | 141.4× | 38.54 | 30.9% | 20.6% | 8.9% | 9.2% | -0.0% |
Dr. Agarwal's Health Care LimitedAGARWALEYE | ₹16,290 Cr | 109.6× | 25.18 | — | 29.4% | 9.5% | 10.8% | +1.5% |
As of Q2 FY27
Financials
Narayana Hrudayalaya Ltd.
NSE: NH · Hospital
Snapshot
Unlock Narayana Hrudayalaya Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Narayana Hrudayalaya Limited is a healthcare provider operating a network of hospitals, clinics, and heart centres. The company offers a wide range of medical specialties including cardiology, oncology, and neurology across India and the Cayman Islands.
Business Model
The company generates revenue through the provision of medical and surgical healthcare services across its hospital network. Additionally, it earns income from healthcare consultancy services and the licensing of proprietary ERP solutions.
- Owned/Operated Hospitals:19
- Managed Hospitals:2
- Heart Centres:4
- Clinics and Information Centres:18
Growth Outlook
Growth is driven by the expansion of the hospital network and the scaling of specialised medical services. The company continues to leverage its healthcare consultancy and technology licensing to diversify revenue streams.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Talent Retention. The company's performance is highly dependent on its ability to attract and retain skilled medical professionals and surgeons.
- Operational Risk. Maintaining high standards of clinical outcomes and patient safety across a geographically dispersed network presents significant operational challenges.
- Competitive Pressure. The healthcare sector in India is highly fragmented and competitive, which may lead to pricing pressures and increased marketing costs.
Start your research today
Unlock AI insights, financials, peers and live data on Narayana Hrudayalaya Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹10,273 Cr
TTM · consolidated
NET PROFIT
₹859 Cr
TTM · consolidated
EPS
₹42.28
TTM · consolidated
RETURN ON EQUITY
19.0%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
15.7%
TTM · consolidated
P/E
43.4x
Q2 FY27 · consolidated
EV/EBITDA
20.6x
Q2 FY27 · consolidated
EBITDA MARGIN
19.9%
TTM · consolidated
NET PROFIT MARGIN
10.6%
Q2 FY27 · consolidated
DEBT TO EQUITY
1.0x
Q2 FY27 · consolidated
Peers · Hospital
As of Q2 FY27